PATENT CLAIM ANALYSIS

Application Number: 15777290
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["424", "186100"]

Abstract:
The invention provides lentiviral preparations containing a sulfonic acid buffer, such as 1,4-piperazinediethanesulfonic acid (PIPES), 2-(N-morpholino)ethanesulfonic acid (MES), and 3-morpholinopropane-1-sulfonic acid (MOPS), a sodium citrate buffer, or a phosphate buffer. The invention additionally encompasses methods of lentiviral purification as well as methods of transducing human cells.

Claim (Index 41):
The aqueous composition of  claim 1 , wherein said aqueous composition is free of one or more proteins selected from the group consisting of human serum albumin (HSA), recombinant human serum albumin (rHSA), bovine serum albumin (BSA), and a lipoprotein, or said lentiviral vector is produced in cells cultured in the absence of serum.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 93.0
- Lexical Diversity: 1.65789
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15106862', '12443153', '15022049', '13277900', '14412844']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7675038291246139
- 35 USC 102 Novelty (BERT): 0.5005164716331533
- Combined Prediction Score: 0.7408050933754678
- Mean Citation Score: 254.641716
- Max Citation Score: 258.30765
- Similarity Product: 185.9236097715944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test